Znanstveni rad - Izvorni znanstveni rad
Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT
Journal of Hematology & Oncology, 12 (2019), 1; 108. https://doi.org/10.1186/s13045-019-0790-x

Pavlů, Jiří; Labopin, Myriam; Niittyvuopio, Riitta; Socié, Gerard; Yakoub-Agha, Ibrahim; Wu, Depei; Remenyi, Peter; Passweg, Jakob; Beelen, Dietrich W.; Aljurf, Mahmoud; Kröger, Nicolaus; Labussière-Wallet, Hélène; Perić, Zinaida; Giebel, Sebastian; Nagler, Arnon; Mohty, Mohamad Više autora...

Citirajte ovaj rad

Pavlů, J., Labopin, M., Niittyvuopio, R., Socié, G., Yakoub Agha, I., Wu, D. ... Mohty, M. (2019). Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT. Journal of Hematology & Oncology, 12. (1). doi: 10.1186/s13045-019-0790-x

Pavlů, Jiří, et al. "Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT." Journal of Hematology & Oncology, vol. 12, br. 1, 2019. https://doi.org/10.1186/s13045-019-0790-x

Pavlů, Jiří, Myriam Labopin, Riitta Niittyvuopio, Gerard Socié, Ibrahim Yakoub Agha, Depei Wu, Peter Remenyi, et al. "Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT." Journal of Hematology & Oncology 12, br. 1 (2019). https://doi.org/10.1186/s13045-019-0790-x

Pavlů, J., et al. (2019) 'Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT', Journal of Hematology & Oncology, 12(1). doi: 10.1186/s13045-019-0790-x

Pavlů J, Labopin M, Niittyvuopio R, Socié G, Yakoub Agha I, Wu D, i sur.. Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT. Journal of Hematology & Oncology [Internet]. 23.10.2019. [pristupljeno 25.03.2024.];12(1). doi: 10.1186/s13045-019-0790-x

J. Pavlů, et al., "Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT", Journal of Hematology & Oncology, vol. 12, br. 1, Listopad 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:030394. [Citirano: 25.03.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.